Track T2 Biosystems, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

T2 Biosystems, Inc. TTOO · Stock Open T2 Biosystems, Inc. in new tab

0.004000 USD
P/E
0.02
EPS
-0.02
P/B
-0.02
Beta
8.46
Loading chart...
Key Metrics
Earnings dateNov. 16, 2026
P/E0.02
EPS-0.02
Book Value-0.62
Price to Book-0.02
% Insiders0.031%
Growth
Revenue Growth0.35%
Estimates
Forward P/E-0.01
Forward EPS-1.19

DCF valuation

Model fair value for T2 Biosystems, Inc. (TTOO)
Result
Sign in to run the valuation for TTOO.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

T2 Biosystems, Inc. Logo T2 Biosystems, Inc. Analysis (TTOO)

United States Health Care Official Website Stock

Is T2 Biosystems, Inc. a good investment? T2 Biosystems, Inc. (TTOO) is currently trading at 0.004000 USD.

In terms of valuation, the stock trades at a P/E ratio of 0.02. This relatively low multiple may signal that T2 Biosystems, Inc. is undervalued compared to historical market norms.

Earnings Schedule: T2 Biosystems, Inc. is expected to release its next earnings report on Nov. 16, 2026. The market consensus estimate for Forward EPS is -1.19.

Investor FAQ

Does T2 Biosystems, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is T2 Biosystems, Inc.?

T2 Biosystems, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Nov. 16, 2026. The company currently has a trailing EPS of -0.02.

Company Profile

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.

Exchange Ticker
NMS (United States) TTOO
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Oct. 13, 2022 1:50
Oct. 13, 2023 1:100
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion